Industry
Lumara Health, Inc.
Total Trials
6
Recruiting
0
Active
0
Completed
6
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 6 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
50%
3 trials in Phase 3/4
Results Transparency
33%
2 of 6 completed trials have results
Key Signals
2 with results
Enrollment Performance
Analytics
Phase 3
3(50.0%)
Phase 2
2(33.3%)
Phase 1
1(16.7%)
6Total
Phase 3(3)
Phase 2(2)
Phase 1(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (6)
Showing 6 of 6 trials
NCT01899846Phase 1Completed
Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood
Role: lead
NCT01389102Phase 3Completed
Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms
Role: lead
NCT00758953Phase 2Completed
Pain Associated With Endometriosis
Role: lead
NCT00694928Phase 3Completed
Vaginal Infection Study 2
Role: lead
NCT00616330Phase 3Completed
Vaginal Infection Study
Role: lead
NCT00590590Phase 2Completed
Safety and Efficacy of Two Vaginal Products Versus Placebo in Patients With Vaginal Discomfort
Role: lead
All 6 trials loaded